Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 08:25 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | LA | 47 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 193031 | RAPIDES PARISH, LA | 47 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 47-bed suburban community hospital in RAPIDES PARISH, LA with $15.0M in net patient revenue and a 13.1% operating margin. The hospital serves a payer mix of 53.3% Medicare, 0.1% Medicaid, and 46.6% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.1% to 20.4% (+736bps).

Net Revenue HCRIS$15.0M
Current EBITDA COMPUTED$2.0M
Operating Margin COMPUTED13.1%
Occupancy HCRIS58.6%
Revenue / Bed COMPUTED$318K
Net-to-Gross HCRIS65.8%
Distress Probability ML51.3%

2. Market Context & Competitive Position

212
LA Hospitals
-3.5%
State Median Margin
112
Comparable Hospitals

LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of 13.1% places it above the state median. Among 112 size-comparable peers (24-94 beds), the median margin is -4.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-94), prioritizing same-state peers. 112 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)LA47$15.0M13.1%
UNIVERSITY HOSPITAL & CLINICSLA52$158.9M-33.4%
SOUTHERN REGIONAL MEDICAL CORPLA64$97.3M-50.0%
OCHSNER LSU HEALTH MONROELA84$85.1M-50.0%
NATCHITOCHES REGIONAL MEDICAL LA81$82.4M-21.8%
LAKE AREA MEDICAL CENTERLA88$81.6M2.2%
NEW ORLEANS EAST HOSPITALLA60$77.6M-29.7%
OCHSNER BAYOU LLCLA25$76.5M-0.9%
OUR LADY OF THE ANGELS HOSPITALA36$76.2M-4.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$314K+210bp18mo
Cost to Collect4.5%2.5%$299K+200bp12mo
Denial Rate Reduction12.0%6.5%$296K+198bp12mo
A/R Days Reduction5200.0%3800.0%$182K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$314K
Cost to Collect
$299K
Denial Rate Reduction
$296K
A/R Days Reduction
$182K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$2.0M
+ RCM Uplift+$1.1M
Pro Forma EBITDA$3.1M
Current Margin13.1%
Pro Forma Margin20.4%
WC Released (1x)$574K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.0M$23.9M7.95x51.4%
Base (11x exit)10.0x11.0x$3.0M$27.3M9.07x55.4%
Bull Case9.0x11.0x$2.7M$31.9M11.78x63.8%
Bull (12x exit)9.0x12.0x$2.7M$35.6M13.14x67.4%
Bear Case11.0x10.0x$3.3M$17.4M5.27x39.4%
Bear (11x exit)11.0x11.0x$3.3M$20.2M6.12x43.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 51.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 112 hospitals with 24-94 beds
  • Same-state prioritization (n=113)
  • Comp margins: P25=-23.5% / P50=-4.9% / P75=4.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.